Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × Exercise × Clear all

Phase

Status

Completed 17 Unknown 4 Active not recruiting 4 Withdrawn 3 Recruiting 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 9 Neoplasms 4 Breast Neoplasms 3 Weight Loss 1 Ventricular Dysfunction, Left 1 Urinary Incontinence 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Lymphoma 1 Leukemia 1 Insulin Resistance 1 Hypoxia 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Fecal Incontinence 1 Fatigue 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Brenner Tumor 1 Breast Diseases 1 Brain Neoplasms 1 Bone Metastases 1 Body Weight 1 Asthenia 1

Interventions

Docetaxel 48 Prednisone 27 Leuprolide 21 enzalutamide 19 bicalutamide 15 Magnetic Resonance Spectroscopy 14 Goserelin 12 Abiraterone Acetate 12 Radiotherapy 11 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10 abiraterone 9 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 olaparib 7 gallium 68 PSMA-11 7 Metformin 7 Ketoconazole 7 Gonadotropin-Releasing Hormone 7 Doxorubicin 7 Cyclophosphamide 7 Androgen Antagonists 7 luprolide acetate gel depot 6 Estramustine 6 pembrolizumab 5 cabozantinib 5 apalutamide 5 Radiosurgery 5 Mitoxantrone 5 Dexamethasone 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡